Bad Deals
This company does not save lives. They offer an alternative source, regarding the vast amounts of molecules that Other Companies may go through when doing their own research or making their own end products, etc.
And those Other-Companies could otherwise just keep getting the same "real" or "natural" molecules they need from their other existing suppliers.
It is not ethical to try and blend what this company does into speculations as to what Other-Companies could or could not do. As if they are both one in the same, just for a self promotional purpose or opinion.
What the company does... is try to develop a substitute or synthetic-like molecule to match ones that may already exist in nature. By a process that may either be less toxic or less expensive for an end user, depending on the type of deal or collaboration that is made. That's what the company does. They don't save lives.
It would be those Other-Companies that would actually be doing any research or trials or whatever, which may or may not lead to something beneficial. All this company does is try to synthetically replicate existing natural molecules that Others-Companies could use, and then tries to sell it to them.
Meanwhile, it seems that sources are putting-together investors and confusing them with mixed-up Forward-Looking Statements. Trying to "blend" a company as if it were something it's not.
And in the process... this company continues to pile on more enormous bad debt, give-away collaborations, massive dilution, convertible notes, warrants, etc.
Misguided investors expected a profit, a positive EPS, and no dilution. But what they got was the complete opposite, as the company proves their insatiable appetite for eating up any and all revenues that come their way.
JMO
